Cargando…
Targeting the Synapse in Alzheimer’s Disease
Dynamic gain and loss of synapses is fundamental to healthy brain function. While Alzheimer’s Disease (AD) treatment strategies have largely focussed on beta-amyloid and tau protein pathologies, the synapse itself may also be a critical endpoint to consider regarding disease modification. Disruption...
Autores principales: | Jackson, Johanna, Jambrina, Enrique, Li, Jennifer, Marston, Hugh, Menzies, Fiona, Phillips, Keith, Gilmour, Gary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664030/ https://www.ncbi.nlm.nih.gov/pubmed/31396031 http://dx.doi.org/10.3389/fnins.2019.00735 |
Ejemplares similares
-
Synapses, Microglia, and Lipids in Alzheimer’s Disease
por: Paasila, Patrick J., et al.
Publicado: (2022) -
Tau Oligomers: The Toxic Player at Synapses in Alzheimer’s Disease
por: Guerrero-Muñoz, Marcos J., et al.
Publicado: (2015) -
Synapses, Synaptic Activity and Intraneuronal Aβ in Alzheimer's Disease
por: Tampellini, Davide, et al.
Publicado: (2010) -
Commentary: APP as a Mediator of the Synapse Pathology in Alzheimer's Disease
por: Schreurs, An, et al.
Publicado: (2018) -
Alzheimer’s disease as a synaptopathy: Evidence for dysfunction of synapses during disease progression
por: Meftah, Soraya, et al.
Publicado: (2023)